NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which drug is associated with a risk of agranulocytosis requiring REMS?

Aripiprazole
Lurasidone
Clozapine
Risperidone

The correct answer is: Clozapine

Clozapine is associated with a risk of agranulocytosis, a potentially life-threatening condition where the body does not produce enough white blood cells. As a result, Clozapine is required to have a Risk Evaluation and Mitigation Strategy (REMS) in place to monitor patients for this side effect. Aripiprazole, Lurasidone, and Risperidone do not carry this risk and therefore do not require REMS.